Skip to main content

Naftifine Topical Dosage

Medically reviewed by Drugs.com. Last updated on May 29, 2023.

Applies to the following strengths: 1%; 2%

Usual Adult Dose for Tinea Corporis

1% CREAM: A sufficient quantity should be gently massaged into the affected and surrounding skin areas once a day.
1% GEL: A sufficient quantity should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening.
2% CREAM: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

Uses:
1% CREAM: For the topical treatment of tinea cruris and tinea corporis due to T rubrum, T mentagrophytes, and Epidermophyton floccosum
1% GEL: For the topical treatment of tinea cruris and tinea corporis due to T rubrum, T mentagrophytes, T tonsurans, and E floccosum
2% CREAM: For the treatment of tinea cruris and tinea corporis due to Trichophyton rubrum

Usual Adult Dose for Tinea Cruris

1% CREAM: A sufficient quantity should be gently massaged into the affected and surrounding skin areas once a day.
1% GEL: A sufficient quantity should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening.
2% CREAM: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

Uses:
1% CREAM: For the topical treatment of tinea cruris and tinea corporis due to T rubrum, T mentagrophytes, and Epidermophyton floccosum
1% GEL: For the topical treatment of tinea cruris and tinea corporis due to T rubrum, T mentagrophytes, T tonsurans, and E floccosum
2% CREAM: For the treatment of tinea cruris and tinea corporis due to Trichophyton rubrum

Usual Adult Dose for Tinea Pedis

1% CREAM: A sufficient quantity should be gently massaged into the affected and surrounding skin areas once a day.
1% GEL: A sufficient quantity should be gently massaged into the affected and surrounding skin areas twice a day in the morning and evening.
2% CREAM: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.
2% GEL: A thin layer should be applied to the affected areas plus an approximate 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

Uses:
1% CREAM: For the topical treatment of tinea pedis due to T rubrum, T mentagrophytes, and E floccosum
1% GEL: For the topical treatment of tinea pedis due to T rubrum, T mentagrophytes, T tonsurans, and E floccosum
2% CREAM: For the treatment of interdigital tinea pedis due to T rubrum
2% GEL: For the treatment of interdigital tinea pedis due to T rubrum, T mentagrophytes, and E floccosum

Usual Pediatric Dose for Tinea Corporis

2 years or older:
2% CREAM: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

Uses: For the treatment of tinea corporis due to T rubrum

Usual Pediatric Dose for Tinea Cruris

12 years or older:
2% CREAM: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

Use: For the treatment of tinea cruris due to T rubrum

Usual Pediatric Dose for Tinea Pedis

12 years or older:
2% CREAM: A thin layer should be applied to the affected areas plus a 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.
2% GEL: A thin layer should be applied to the affected areas plus an approximate 1/2 inch margin of healthy surrounding skin once a day for 2 weeks.

Uses:
2% CREAM: For the treatment of interdigital tinea pedis due to T rubrum
2% GEL: For the treatment of interdigital tinea pedis due to T rubrum, T mentagrophytes, and E floccosum

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

  • Hypersensitivity to any of the ingredients (1% cream and gel)
  • None (2% cream and gel)

1% Cream and Gel: Safety and efficacy have not been established in patients younger than 18 years.
2% Cream:
  • Treatment of tinea corporis: Safety and efficacy have not been established in patients younger than 2 years.
  • Treatment of tinea cruris and interdigital tinea pedis: Safety and efficacy have not been established in patients younger than 12 years.
2% Gel: Safety and efficacy have not been established in patients younger than 12 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

  • Wash hands after application.
  • Only use topically; not for ophthalmic, oral, or intravaginal use.

General:
  • Diagnosis of the disease should be confirmed by direct microscopic examination or by culture.
  • Patients should be reevaluated if no clinical improvement is seen after 4 weeks of therapy with the 1% formulations.

Patient advice:
  • Keep this drug away from the eyes, nose, mouth, and other mucous membranes.
  • Consult the physician if irritation or sensitivity develops after use.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.